TriSalus Life Sciences TLSI Cash Flow Statement (2021-2026)

NASDAQ TLSI
$5.32 -0.17 (-3.10%)
At close: Aug 20, 2026 · 12:08 PM UTC
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
1.86M2.90M2.84M2.39M-8.09M-22.54M-8.27M-13.97M-1.43M-35.64M-13.21M-4.33M-2.40M-10.11M-10.38M-8.29M-10.81M-9.75M1.54M-9.19M
Share-based Compensation (Quarter)
0.12M0.07M-0.07M0.40M-0.40M1.09M1.27M-1.90M4.98M1.62M1.89M-3.51M9.13M2.47M2.62M
Gains from Investment Securities (Quarter)
-2.39M-19.90M9.61M3.99M-13.69M-2.36M0.83M0.82M-0.70M-2.52M5.15M-7.40M1.00M
Asset Writedowns and Impairment (Quarter)
0.19M0.04M0.06M0.03M
Cash from Operations (Quarter)
-0.37M-0.68M-0.43M-0.70M-22.88M-8.31M-10.50M-9.24M-21.66M-9.18M-10.87M-13.42M-10.85M-5.71M-4.50M-7.32M-3.71M-2.48M-6.48M-10.13M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.15M0.23M0.23M0.27M0.32M
Amortization of Deferred Charges (Quarter)
0.01M-0.01M0.13M-0.13M0.08M0.24M0.36M0.49M0.17M0.77M0.56M-0.00M0.03M0.34M
Depreciation & Amortization (CF) (Quarter)
-0.05M0.18M0.15M0.16M0.19M0.17M0.19M0.18M0.19M0.17M0.17M0.16M0.13M0.14M0.14M
Change in Working Capital
Change in Receivables (Quarter)
-0.74M0.04M0.50M0.94M0.50M0.72M0.43M0.21M0.36M0.37M0.17M-0.50M1.59M-1.29M1.27M
Change in Inventory (Quarter)
0.18M0.25M-0.20M0.11M0.92M0.37M0.53M0.56M0.05M0.11M-0.35M-0.53M-0.20M0.70M0.43M
Change in Accured Expenses (Quarter)
0.34M0.36M0.21M-0.51M1.40M4.14M0.02M2.04M-4.63M5.41M-0.30M-2.35M-2.02M0.30M1.62M-1.81M1.51M0.69M0.16M-0.59M
Change in Taxes (Quarter)
0.14M-0.14M0.03M-0.02M
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
-0.44M0.01M0.03M0.18M0.37M0.07M0.06M0.17M-0.29M0.09M-0.07M0.86M-0.81M0.14M0.08M
Sales of Property, Plant and Equipment (Quarter)
0.04M0.04M
Cash from Investing Activities (Quarter)
0.01M0.08M-1.60M-0.27M-0.07M-0.03M-1.11M-0.37M-0.07M-0.06M-0.17M-0.05M-0.71M0.09M-0.18M-0.04M-0.14M-0.08M
Financing Activities
Other financing activities (Quarter)
0.02M0.05M9.55M0.03M-9.45M0.01M0.01M0.00M0.06M0.28M0.06M0.09M-0.02M0.03M0.24M
Cash from Financing Activities (Quarter)
0.27M0.64M6.65M5.91M7.93M6.40M40.25M0.04M3.13M25.99M5.82M2.99M9.69M20.72M0.08M0.28M42.38M-0.05M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
3.14M3.60M5.84M2.52M22.21M-0.21M42.62M
Additional items
Change in Cash (Quarter)
-0.37M-0.08M-0.15M0.02M-17.83M-2.67M-2.65M-2.86M17.48M-9.51M-7.81M12.51M-5.19M-2.76M4.47M13.49M-3.80M-2.25M35.76M-10.27M
Free Cash Flow (Quarter)
-0.37M-0.68M-0.43M-0.70M-22.88M-7.87M-10.51M-9.27M-21.84M-9.55M-10.93M-13.48M-11.02M-5.41M-4.59M-7.25M-4.57M-1.68M-6.62M-10.21M
Net Cash Flow (Quarter)
-0.37M-0.68M-0.15M0.02M-17.83M-2.67M-2.65M-2.86M17.48M-9.51M-7.81M12.51M-5.19M-2.76M4.47M13.49M-3.80M-2.25M35.76M-10.27M